GLP-1 weight-loss drugs

Oregon’s wine industry is in the middle of a sharp market correction — driven by a 25% drop in 2025 grape production and a 16% decline in sales — for a variety of unrelated reasons.

A bill to require that health insurance plans for public employees cover weight-loss drugs is running into opposition from the California Public Employees Retirement System.